Analysis of gene expression during the first 10 weeks following PEG-interferon-alfa2B/ribavirin treatment of a group of hepatitis C raments

被引：0
|
作者：
Taylor, Milton W.
Tsukahara, Takurna
Kwo, Paul
机构：
[1] Indiana Univ, Bloomington, IN USA
[2] Indiana Univ, Sch Med, Indianapolis, IN 46204 USA
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
283
引用
收藏
页码：365A / 365A
页数：1
相关论文
共 50 条
  • [1] Cyclic changes in gene expression induced by Peg-interferon alfa-2b plus ribavirin in peripheral blood monocytes (PBMC) of hepatitis C patients during the first 10 weeks of treatment
    Taylor, Milton W.
    Tsukahara, Takuma
    McClintick, Jeanette N.
    Edenberg, Howard J.
    Kwo, Paul
    JOURNAL OF TRANSLATIONAL MEDICINE, 2008, 6 (1)
  • [2] Cyclic changes in gene expression induced by Peg-interferon alfa-2b plus ribavirin in peripheral blood monocytes (PBMC) of hepatitis C patients during the first 10 weeks of treatment
    Milton W Taylor
    Takuma Tsukahara
    Jeanette N McClintick
    Howard J Edenberg
    Paul Kwo
    Journal of Translational Medicine, 6
  • [3] PEG-Interferon alfa2b plus ribavirin treatment in chronic hepatitis C
    Müller, T
    MONATSSCHRIFT KINDERHEILKUNDE, 2005, 153 (12) : 1192 - 1192
  • [4] Gene expression involving interferon-regulatory innate immunity and resistance to PEG-interferon alfa-2b plus ribavirin treatment in chronic hepatitis C
    Asahina, Yasuhiro
    Izumi, Namiki
    Komatsu, Nobutoshi
    Umeda, Naoki
    Hosokawa, Takanori
    Ueda, Ken
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Itakura, Jun
    Kurosaki, Masayuki
    Uchihara, Masakatsu
    Miyake, Shozo
    HEPATOLOGY, 2006, 44 (04) : 220A - 221A
  • [5] Peg-interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4
    Shiha, G.
    Abass, B.
    El-Shenawy, H.
    Zalata, K.
    Attia, M.
    Farouk, D.
    LIVER INTERNATIONAL, 2006, 26 : 79 - 79
  • [6] Changes in gene expression induced by Pegintron plus ribavirin in PBMC of Hepatitis C patients during the first 10 weeks of treatment
    Taylor, Milton W.
    Tsukahara, Takuma
    McClintick, Jeanette N.
    Edenberg, Howard J.
    Kwo, Paul
    CYTOKINE, 2008, 43 (03) : 282 - 282
  • [7] Treatment with Peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia
    Saadoun, D
    Cacoub, P
    JOURNAL OF HEPATOLOGY, 2005, 43 (04) : 737 - 737
  • [8] Treatment with Peg-Interferon alfa-2b (PEG-IFN) plus ribavirin compared to interferon alfa-2b (INF alfa-2b)plus ribavirin on subjects with chronic hepatitis C infected with HCV genotype 4.
    Esmat, G
    Abouzied, AM
    Abdel-Aziz, F
    Mohamed, MK
    Abdel-Hamid, M
    El Raziky, MS
    Ismail, SA
    Zalata, KR
    Mikhail, NN
    Fix, A
    Strickland, T
    Sjogren, MH
    HEPATOLOGY, 2002, 36 (04) : 364A - 364A
  • [9] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    PN Rao
    Abraham Koshy
    Jacob Philip
    Narayanan Premaletha
    Joy Varghese
    Krishnasamy Narayanasamy
    Samir Mohindra
    Nitin Vikas Pai
    Manoj Kumar Agarwal
    Ashokna Konar
    Hasmukh B Vora
    World Journal of Hepatology, 2014, (07) : 520 - 526
  • [10] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    Rao, P. N.
    Koshy, Abraham
    Philip, Jacob
    Premaletha, Narayanan
    Varghese, Joy
    Narayanasamy, Krishnasamy
    Mohindra, Samir
    Pai, Nitin Vikas
    Agarwal, Manoj Kumar
    Konar, Ashoknanda
    Vora, Hasmukh B.
    WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (07) : 520 - 526
12345